Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/1999
05/27/1999WO1999025832A1 Toso
05/27/1999WO1999025829A2 Cdk2 protein and cdk2 protein complexes
05/27/1999WO1999025825A2 EXTENDED cDNAs FOR SECRETED PROTEINS
05/27/1999WO1999025818A1 Method of identifying binding site domains that retain the capacity of binding to an epitope
05/27/1999WO1999025817A2 Tc1-based transposon vectors
05/27/1999WO1999025815A2 Nucleic acids involved in the responder phenotype and applications thereof
05/27/1999WO1999025814A1 Genetically-modified myogenic progenitors and their use in cell and gene therapy
05/27/1999WO1999025813A1 Method for inducing osteoblast differentiation of human extramedullary adipose tissue cells
05/27/1999WO1999025812A1 Method for the production and use of dendritic cells
05/27/1999WO1999025811A1 Epidermal cell growth activating material
05/27/1999WO1999025810A1 Transgenic animal models for human bladder cancer
05/27/1999WO1999025734A2 Th2 CELL DEPLETION; COMPOSITIONS; METHODS
05/27/1999WO1999025396A2 Hybrid tissues for tissue engineering
05/27/1999WO1999025391A2 Biodegradable polymer scaffold
05/27/1999WO1999025379A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999WO1999025378A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999WO1999025377A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
05/27/1999WO1999025367A2 Treatment of hematologic disorders
05/27/1999WO1999025366A1 Use of cytokines and mitogens to inhibit pathological immune responses
05/27/1999WO1999025195A1 Purging of stem cell products
05/27/1999WO1999014330A8 DcR3 POLYPEPTIDE, A TNFR HOMOLOG
05/27/1999WO1999012964A3 Kay - a novel immune system protein
05/27/1999WO1999011758A3 Cultures of human cns neural stem cells
05/27/1999WO1999003976A3 Method of treating leukocytes, leukocyte compositions and methods of use thereof
05/27/1999WO1999000152A3 Biosynthetic transplant and method for the production thereof
05/27/1999CA2310563A1 Vector for tissue-specific replication and gene expression
05/27/1999CA2310328A1 Purging of stem cell products
05/27/1999CA2310269A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999CA2310228A1 Attaching substances to micro-organisms
05/27/1999CA2310016A1 Genetically-modified myogenic progenitors and their use in cell and gene therapy
05/27/1999CA2309990A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999CA2309919A1 Treatment of hematologic disorders
05/27/1999CA2309904A1 Transfection and transfer of male germ cells for generation of transgenic species
05/27/1999CA2309807A1 Transgenic models of inflammatory disease
05/27/1999CA2309761A1 Th2 cell depletion; compositions; methods
05/27/1999CA2309758A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999CA2309757A1 Stress resistance gene
05/27/1999CA2309390A1 Cdk2 protein and cdk2 protein complexes
05/27/1999CA2309343A1 Toso
05/27/1999CA2309000A1 Tc1-based transposon vectors
05/27/1999CA2308571A1 Single-chain bifunctional glycoprotein hormones
05/27/1999CA2308365A1 Dna19355 polypeptide, a tumor necrosis factor homolog
05/27/1999CA2307539A1 Improvements relating to protein accumulation
05/27/1999CA2306492A1 Human checkpoint kinase, hcds1, compositions and methods
05/27/1999CA2302644A1 Extended cdnas for secreted proteins
05/26/1999EP0917879A2 Procédé amélioré pour la stabilisation des protéines
05/26/1999EP0917877A1 Remedies/preventives for viral infections, process for preparing the same, and method for preventing/treating viral infections
05/26/1999EP0917584A1 Modified tomato mottle geminivirus coat protein gene
05/26/1999EP0917579A1 Vertebrate telomerase genes and proteins and uses thereof
05/26/1999EP0917577A2 Herpes simplex virus icp4 is an inhibitor of apoptosis
05/26/1999EP0917572A2 Secreted proteins and polynucleotides encoding them
05/26/1999EP0917538A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
05/26/1999EP0917536A2 Polynucleotide and its use for modulating a defence response in plants
05/26/1999EP0917469A1 Methods for inducing bone formation
05/26/1999EP0917428A1 Hybrid matrix implants and explants
05/26/1999EP0668910B1 Human neuropeptide y-y1 receptor
05/26/1999EP0616641B1 Humanized b-b10, an anti-il2 receptor antibody
05/26/1999CN1217751A Parapoxvirus vectors
05/26/1999CN1217750A Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system
05/26/1999CN1217748A Transferrin receptor genes of moraxella
05/26/1999CN1217746A Pluripotent rabbit embryonic stem (ES) cell lines and their use in generation of chimeric rabbits
05/26/1999CN1217745A Cell culture media for mammalian cells
05/26/1999CN1217632A Method of protein production using mitochondrial translation system
05/26/1999CN1217339A Cellulose binding domain
05/25/1999US5907086 Plant promoter sequences
05/25/1999US5907034 With same affinity to ethylenediamine tetraacetic acid and diethylenetriamine pentaacetic acid as to their complexes with manganese, cadmium, zinc, copper, yttrium, or lead
05/25/1999US5906941 Homogenous mixture of culture medium and fishery by-product such as protein hydrolyzates; enhances somatic embryo formation
05/25/1999US5906939 Cultured fibroblast or epithelial cell dissociation method using sulfated polysaccharide and chelator
05/25/1999US5906938 Method of reconstituting hematopoietic cells using monoclonal antibodies to the stem cell factor receptor
05/25/1999US5906937 Seeding cells on collagen support having projections forming penetrating pores in skin matrix; propagating tissues for use as grafts for burns and other injuries
05/25/1999US5906934 Mesenchymal stem cells for cartilage repair
05/25/1999US5906930 Nucleic acid coding for mutant enzyme; for removal of carboxy acid protecting groups during synthesis of antibiotics like loracarbef
05/25/1999US5906928 Efficient gene transfer into primary murine lymphocytes obviating the need for drug selection
05/25/1999US5906828 Cell growth substrates with tethered cell growth effector molecules
05/25/1999US5906821 Viral nucleotide sequences
05/25/1999US5906817 Biocompatible implant for the expression and in vivo secretion of a therapeutic substance
05/25/1999CA2189646C A purified mixture of collagenases and two other proteases obtained from clostridium histolyticum
05/25/1999CA1340565C Device and process for cell capture and recovery
05/25/1999CA1340557C Ckmb assay and monoclonal antibodies for use in same
05/21/1999CA2251257A1 Oncogene- or virus-controlled expression systems
05/20/1999WO1999024836A1 125 human secreted proteins
05/20/1999WO1999024617A1 Methods and compositions for peptide libraries displayed on light-emitting scaffolds
05/20/1999WO1999024601A1 Secreted protein nsl4
05/20/1999WO1999024595A1 The translation enhancer element of the human amyloid precursor protein gene
05/20/1999WO1999024594A1 Gene coding for thanatin, vector containing same and resulting transformed disease-resistant plants
05/20/1999WO1999024593A1 Nucleic acid molecules which encode proteins having fructosyl transferase activity and methods for producing long-chain inulin
05/20/1999WO1999024586A1 Chimeric hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining plants containing such a gene, with herbicide tolerance
05/20/1999WO1999024585A1 Mutated hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining herbicide-tolerant plants containing such gene
05/20/1999WO1999024582A1 Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
05/20/1999WO1999024581A2 Plant-optimized genes encoding pesticidal toxins
05/20/1999WO1999024576A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
05/20/1999WO1999024575A1 dull1 CODING FOR A STARCH SYNTHASE AND USES THEREOF
05/20/1999WO1999024572A1 Genes with restricted expression in mesencephalic dopaminergic neurons
05/20/1999WO1999024571A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
05/20/1999WO1999024570A1 Ciita-interacting proteins and methods of use therefor
05/20/1999WO1999024567A1 Tissue cement proteins from rhipicephalus appendiculatus
05/20/1999WO1999024562A1 Method of increasing efficiency of directed evolution of a gene using phagemid
05/20/1999WO1999024559A2 Nuclear targeting by means of streptococcal protein h
05/20/1999WO1999024557A1 Human bone accessory cells
05/20/1999WO1999024556A1 Novel culture medium which comprises fetal porcine serum (fps)